Andean Precious Metals (CVE:APM) Given New C$1.70 Price Target at Desjardins

Andean Precious Metals (CVE:APM) had its price objective boosted by Desjardins from C$1.60 to C$1.70 in a report published on Tuesday, BayStreet.CA reports. The brokerage currently has a buy rating on the stock.

Andean Precious Metals Stock Performance

CVE:APM opened at C$1.00 on Tuesday. Andean Precious Metals has a 12 month low of C$0.53 and a 12 month high of C$1.11. The stock has a 50-day moving average of C$1.02. The stock has a market cap of C$149.36 million, a PE ratio of 2.63 and a beta of 1.14.

Andean Precious Metals Company Profile

Aptorum Group Limited, a pharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of diseases with a focus on infectious diseases and cancers. Its pipeline enables the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platform for treatments of metabolic diseases.